Asymptomatic Pulmonary Tuberculosis in a Child under TNF-alpha Inhibitor Therapy

The use of TNF-alpha inhibitor agents facilitates mycobacterial infections. Unlike in normal population, active tuberculosis in such patients may be asymptomatic. Here we present the case of an asymptomatic child who developed pulmonary tuberculosis during TNF-alpha inhibitor therapy. A 12-year-old...

Full description

Bibliographic Details
Main Authors: Manolya Acar, Fatih Karagözlü, Murat Sütçü, Oğuz Bülent Erol, Selda Hancerli Torun, Nuran Salman, Ayper Somer
Format: Article
Language:English
Published: Galenos Yayinevi 2017-03-01
Series:İstanbul Medical Journal
Subjects:
Online Access: http://imj.galenos.com.tr/archives/archive-detail/article-preview/asymptomatic-pulmonary-tuberculosis-in-a-child-und/20430
_version_ 1797907409661853696
author Manolya Acar
Fatih Karagözlü
Murat Sütçü
Oğuz Bülent Erol
Selda Hancerli Torun
Nuran Salman
Ayper Somer
author_facet Manolya Acar
Fatih Karagözlü
Murat Sütçü
Oğuz Bülent Erol
Selda Hancerli Torun
Nuran Salman
Ayper Somer
author_sort Manolya Acar
collection DOAJ
description The use of TNF-alpha inhibitor agents facilitates mycobacterial infections. Unlike in normal population, active tuberculosis in such patients may be asymptomatic. Here we present the case of an asymptomatic child who developed pulmonary tuberculosis during TNF-alpha inhibitor therapy. A 12-year-old child with a diagnosis of juvenile idiopathic arthritis and uveitis was referred to our clinic before initiation of adalimumab therapy. His tuberculin skin test was negative and chest X-ray was normal prior to therapy. On the third month of his therapy, his father was diagnosed with pulmonary tuberculosis, and he was initiated on isoniazid therapy. A month later, the patient’s tuberculin skin test was measured as 7 mm, and chest X-ray revealed paratracheal opacity. Computerized tomographic scan confirmed a necrotic mass lesion with a size of 40x27x24 mm which was compatible with tuberculosis. He was thus initiated on antituberculosis therapy. Patients undergoing anti TNF-alpha therapy should be followed up for tuberculosis before and during therapy.
first_indexed 2024-04-10T10:37:21Z
format Article
id doaj.art-110500094174499a9bd059d8bd2257aa
institution Directory Open Access Journal
issn 2619-9793
2148-094X
language English
last_indexed 2024-04-10T10:37:21Z
publishDate 2017-03-01
publisher Galenos Yayinevi
record_format Article
series İstanbul Medical Journal
spelling doaj.art-110500094174499a9bd059d8bd2257aa2023-02-15T16:20:48ZengGalenos Yayineviİstanbul Medical Journal2619-97932148-094X2017-03-01181474910.5152/imj.2017.9705913049054Asymptomatic Pulmonary Tuberculosis in a Child under TNF-alpha Inhibitor TherapyManolya Acar0Fatih Karagözlü1Murat Sütçü2Oğuz Bülent Erol3Selda Hancerli Torun4Nuran Salman5Ayper Somer6 Division of Pediatric Infection and Clinical Immunology, İstanbul University İstanbul School of Medicine, İstanbul, Türkiye Division of Pediatric Infection and Clinical Immunology, İstanbul University İstanbul School of Medicine, İstanbul, Türkiye Division of Pediatric Infection and Clinical Immunology, İstanbul University İstanbul School of Medicine, İstanbul, Türkiye Department of Radiology, İstanbul University İstanbul School of Medicine, İstanbul, Türkiye Division of Pediatric Infection and Clinical Immunology, İstanbul University İstanbul School of Medicine, İstanbul, Türkiye Division of Pediatric Infection and Clinical Immunology, İstanbul University İstanbul School of Medicine, İstanbul, Türkiye Division of Pediatric Infection and Clinical Immunology, İstanbul University İstanbul School of Medicine, İstanbul, Türkiye The use of TNF-alpha inhibitor agents facilitates mycobacterial infections. Unlike in normal population, active tuberculosis in such patients may be asymptomatic. Here we present the case of an asymptomatic child who developed pulmonary tuberculosis during TNF-alpha inhibitor therapy. A 12-year-old child with a diagnosis of juvenile idiopathic arthritis and uveitis was referred to our clinic before initiation of adalimumab therapy. His tuberculin skin test was negative and chest X-ray was normal prior to therapy. On the third month of his therapy, his father was diagnosed with pulmonary tuberculosis, and he was initiated on isoniazid therapy. A month later, the patient’s tuberculin skin test was measured as 7 mm, and chest X-ray revealed paratracheal opacity. Computerized tomographic scan confirmed a necrotic mass lesion with a size of 40x27x24 mm which was compatible with tuberculosis. He was thus initiated on antituberculosis therapy. Patients undergoing anti TNF-alpha therapy should be followed up for tuberculosis before and during therapy. http://imj.galenos.com.tr/archives/archive-detail/article-preview/asymptomatic-pulmonary-tuberculosis-in-a-child-und/20430 ChildTNF-alpha inhibitortuberculosis
spellingShingle Manolya Acar
Fatih Karagözlü
Murat Sütçü
Oğuz Bülent Erol
Selda Hancerli Torun
Nuran Salman
Ayper Somer
Asymptomatic Pulmonary Tuberculosis in a Child under TNF-alpha Inhibitor Therapy
İstanbul Medical Journal
Child
TNF-alpha inhibitor
tuberculosis
title Asymptomatic Pulmonary Tuberculosis in a Child under TNF-alpha Inhibitor Therapy
title_full Asymptomatic Pulmonary Tuberculosis in a Child under TNF-alpha Inhibitor Therapy
title_fullStr Asymptomatic Pulmonary Tuberculosis in a Child under TNF-alpha Inhibitor Therapy
title_full_unstemmed Asymptomatic Pulmonary Tuberculosis in a Child under TNF-alpha Inhibitor Therapy
title_short Asymptomatic Pulmonary Tuberculosis in a Child under TNF-alpha Inhibitor Therapy
title_sort asymptomatic pulmonary tuberculosis in a child under tnf alpha inhibitor therapy
topic Child
TNF-alpha inhibitor
tuberculosis
url http://imj.galenos.com.tr/archives/archive-detail/article-preview/asymptomatic-pulmonary-tuberculosis-in-a-child-und/20430
work_keys_str_mv AT manolyaacar asymptomaticpulmonarytuberculosisinachildundertnfalphainhibitortherapy
AT fatihkaragozlu asymptomaticpulmonarytuberculosisinachildundertnfalphainhibitortherapy
AT muratsutcu asymptomaticpulmonarytuberculosisinachildundertnfalphainhibitortherapy
AT oguzbulenterol asymptomaticpulmonarytuberculosisinachildundertnfalphainhibitortherapy
AT seldahancerlitorun asymptomaticpulmonarytuberculosisinachildundertnfalphainhibitortherapy
AT nuransalman asymptomaticpulmonarytuberculosisinachildundertnfalphainhibitortherapy
AT aypersomer asymptomaticpulmonarytuberculosisinachildundertnfalphainhibitortherapy